Co‐Administration of LNP‐sgFAT1 and CPI‐613 Demonstrates Enhanced Antitumor Efficacy Compared to Either Agent Alone in Orthotopic Mice Bearing Head and Neck Tumors with Mutant FAT1. Here, FAT1 is linked to head and neck neoplasm.